Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France
· Delayed Price · Currency is EUR 0.586
-0.052 (-8.15%)
At close: Mar 6, 2026
EPA:ALOPM Market Cap
EPA:ALOPM has a market cap or net worth of €11.56 million as of March 6, 2026. Its market cap has increased by 76.28% in one year.
Market Cap
11.56M
Enterprise Value
15.64M
Revenue
1.74M
Ranking
n/a
PE Ratio
1.84
Stock Price
€0.59
Market Cap Chart
Since October 5, 2022, EPA:ALOPM's market cap has increased from 5.82M to 11.56M, an increase of 98.53%. That is a compound annual growth rate of 22.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 11.56M | 54.85% |
| Dec 31, 2025 | 7.47M | -42.44% |
| Dec 31, 2024 | 12.97M | -56.74% |
| Dec 29, 2023 | 29.99M | 155.14% |
| Dec 30, 2022 | 11.75M | 101.80% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Plant Advanced Technologies | 9.33M |
| TME Pharma | 6.86M |
| NFL Biosciences | 13.31M |
| Poxel | 13.43M |
| Quantum Genomics Société Anonyme | 5.03M |
| Aton | 4.80M |
| Aelis Farma | 17.13M |
| GenSight Biologics | 18.52M |